Efficacy of PI3K inhibitors in advanced breast cancer
Author:
Funder
Novartis
AstraZeneca
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/30/Supplement_10/x12/31575000/mdz381.pdf
Reference91 articles.
1. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism;Engelman;Nat Rev Genet,2006
2. The PI3K pathway in human disease;Fruman;Cell,2017
3. The emerging mechanisms of isoform-specific PI3K signalling;Vanhaesebroeck;Nat Rev Mol Cell Biol,2010
4. PI3K in lymphocyte development, differentiation and activation;Okkenhaug;Nat Rev Immunol,2003
5. Signalling by PI3K isoforms: insights from gene-targeted mice;Vanhaesebroeck;Trends Biochem Sci,2005
Cited by 162 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genomic biology and therapeutic strategies of liver metastasis from gastric cancer;Critical Reviews in Oncology/Hematology;2024-10
2. Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia;2024-09-12
3. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09
4. A Perspective of PI3K/AKT/mTOR Pathway Inhibitors to Overcome Drug-resistance in Breast Cancer Therapy;Current Medicinal Chemistry;2024-08-21
5. CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling;Discover Oncology;2024-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3